ETrade Capital Management’s West Pharmaceutical WST Stock Holding History

ETrade Capital Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$564K	Sell	2,053 -2,500	-55%	-$662K	0.01%	529
2020 Q2	$1.03M	Sell	4,553 -7,884	-63%	-$1.55M	0.02%	336
2020 Q1	$1.89M	Buy	12,437 +649	+6%	+$99.9K	0.05%	201
2019 Q4	$1.77M	Sell	11,788 -1,746	-13%	-$254K	0.04%	228
2019 Q3	$1.92M	Buy	13,534 +662	+5%	+$91.1K	0.05%	217
2019 Q2	$1.61M	Buy	12,872 +2,752	+27%	+$325K	0.04%	246
2019 Q1	$1.11M	Buy	10,120 +3,755	+59%	+$391K	0.03%	304
2018 Q4	$624K	Sell	6,365 -395	-6%	-$42.9K	0.02%	428
2018 Q3	$835K	Buy	6,760 +1,256	+23%	+$141K	0.02%	412
2018 Q2	$546K	Buy	5,504 +467	+9%	+$43K	0.02%	513
2018 Q1	$445K	Buy	5,037 +1,578	+46%	+$148K	0.01%	546
2017 Q4	$341K	Buy	+3,459	New	+$339K	0.01%	595

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

ETrade Capital Management's WST Position: Q3 2020 in Review

ETrade Capital Management reduced its West Pharmaceutical (WST) stake by 55% in Q3 2020, selling an estimated $662K and leaving 2,053 shares worth $564K. The position accounts for 0.01% of the portfolio, ranked #529.

ETrade Capital Management first reported a position in WST in Q4 2017 and has held it in 12 quarters since. The position peaked at $1.92M in Q3 2019. 574 funds tracked by Wall St. Rank hold WST as of Q3 2020.

ETrade Capital Management held 2,053 shares of West Pharmaceutical worth $564K as of Q3 2020.
ETrade Capital Management sold 2,500 West Pharmaceutical shares in Q3 2020, an estimated $662K.
West Pharmaceutical made up 0.01% of ETrade Capital Management's portfolio in Q3 2020, its #529 holding.
ETrade Capital Management first reported a position in West Pharmaceutical in Q4 2017 and has held it in 12 quarters since.
ETrade Capital Management's West Pharmaceutical position peaked at $1.92M in Q3 2019.
574 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.